Dr. Presant on Adjusting Clinical Trials to Value-Based Care

Cary Presant, MD, FACP, FASCO
Published Online: Thursday, Mar 30, 2017


Cary Presant, MD, FACP, FASCO, City of Hope Medical Center, discusses how clinical trials can be changed to better align with value-based care.

Currently, there is a trend toward changing care from volume-based to value-based. Clinical trials are not value-based, what with the expenses: more testing, more evaluations, more interactions with the clinical trial team and more resources used. 

To adjust for that, there are strategies that can create more value-based clinical trials. Choosing trials carefully, keeping an adequate team caring for the patient throughout the trial process, using resources efficiently, and ensuring buy-in from the entire team can help to adjust the trial system. Adjusting clinical trials currently is necessary as the reliance of value-based care becomes more acute in the future.

Cary Presant, MD, FACP, FASCO, City of Hope Medical Center, discusses how clinical trials can be changed to better align with value-based care.

Currently, there is a trend toward changing care from volume-based to value-based. Clinical trials are not value-based, what with the expenses: more testing, more evaluations, more interactions with the clinical trial team and more resources used. 

To adjust for that, there are strategies that can create more value-based clinical trials. Choosing trials carefully, keeping an adequate team caring for the patient throughout the trial process, using resources efficiently, and ensuring buy-in from the entire team can help to adjust the trial system. Adjusting clinical trials currently is necessary as the reliance of value-based care becomes more acute in the future.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 12th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®Apr 29, 20172.0
Cancer Summaries and Commentaries™: 2016 Conference Coverage: Advances in the Treatment of Genitourinary CancersApr 29, 20172.5
Publication Bottom Border
Border Publication